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PreviewsIn this issue of Chemistry & Biology,
Jahnsen et al. (2013) analyze the mode
of action of a host defense peptide called
HDP4 (Jahnsen et al., 2012). HDP4 is a
16-mer that has an unusual structure of
alternating lysine and N-benzylglycine
residues. The N-substitution blocks enzy-
matic degradation of HDP4. Moreover,
HDP4 exhibits very low toxicity in
mammalian cells (Jahnsen et al., 2012),
making it an interesting candidate for
further study and development.
Jahnsen et al. (2013) show that HDP4 is
active against a broad spectrum of Gram-
negative bacteria. HDP4 is shown to bind
to bacterial membranes and alter their
structure, but quantitative analysis of
these effects with respect to the MIC
reveal that this cannot be the sole mode
of killing. Indeed, the authors create a flu-
orescently labeled version of the peptideand show that it is broadly distributed in
the bacterial cell, not simply localized to
the membrane. It appears to bind to bac-
terial DNA and probably a variety of other
macromolecules in the cells. Treatment of
bacteria with HDP4 inhibits the formation
of biofilms. In addition, the peptide has
significant effects on host cell responses
to infection as well. It stimulates the
release of chemokines such as IL-8, but
suppresses LPS-induced inflammatory
responses, such as the release of the
proinflammatory TNF-a. As one might
expect from this multimodal killing mech-
anism, the authors demonstrate that bac-
teria are unable to develop resistance to
HDP4 with anywhere near the efficiency
observed for drugs with a single enzy-
matic target.
It is quite remarkable that such a simple
molecule, containing only two differentChemistry & Biology 20, October 24, 2013 ªresidues, is able to exert somany different
effects. Clearly, much work remains to be
done in order to understand these events
in more detail. Nonetheless, from a prac-
tical point of view, the data are intriguing.
The authors argue that this interesting
combination of a simple structure, proteo-
lytic stability, very low mammalian cell
toxicity, and multimodal mechanism of
action merit further investigation of
HDP4 or derivatives as potential clinical
candidates.REFERENCES
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Fluorescent proteins are used as noninvasive tags for protein trafficking, structure, and action. In this issue of
Chemistry & Biology, Hoi and colleagues present a new optimized zFP538 yellow fluorescent protein called
mPapaya1 that is bright, monomeric, and an excellent fusion partner for cellular proteins.Imaging proteins fused to fluorescent pro-
teins (FPs) is a cornerstone of modern
cellular biology and biophysics (Crivat
and Taraska, 2012). This method allows
proteins to be observed and studied in
living cells, tissues, and organisms. FPs
that are bright, structurally stable, and
monomeric are generally the best
choice to noninvasively tag a protein part-
ner for live cell imaging. A tremendous
amount of work over the last 15 years
through protein engineering, directed
evolution, and the discovery new FPs
from different organisms has led to the
development of many excellent FPs
that span the visible spectrum (Crivat
and Taraska, 2012).Some notable holes, however, in the
FP toolset have been difficult to fill. For
example, no stable bright monomeric
FPs with emissions sitting in the yellow
region between 530 nm and 560 nm
have been found (Davidson and Camp-
bell, 2009). This spectral gap rests
between the most red-shifted Aequorea
victoria GFP mutants and the most
blue-shifted Discosoma red FP (dsRed)
variants. Red-shifted GFP variants such
as mVenus and mCitrine have the closest
emission peaks at 528 and 529 nm,
respectively. These proteins have a
tyrosine at position 203 that interacts
via p-p stacking with the Tyr66-derived
phenol ring of the chromophore. Thep-electron orbital of Tyr203 is thought
to affect the electronic transition of the
chromophore to red-shift the emission
wavelength (Davidson and Campbell,
2009). Along with other folding and
stabilization mutations, these proteins
have become useful bright yellow FPs
(YFPs). Their utility as fluorescence reso-
nance energy transfer (FRET) acceptors,
however, has been controversial. Some
reports have shown that photo-bleaching
of YFP-like proteins can generate a cyan
FP-like species (Kirber et al., 2007; Val-
entin et al., 2005). This spurious color
switching could seriously skew quan-
titative FRET measurements. Others,






















Figure 1. Yellow Fluorescent Protein from Zoanthus sp.
(A) The Zoanthus button polyp.
(B and C) The crystal structure of the yellow fluorescent protein zFP538 and its chromophore (C).
(D) The emission spectrum of the mPapaya1 protein (white line). The emission peak is at 541 nm.
Photo of Zoanthus sp. courtesy of Coral Morphologic.
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So¨ling, 2006). Cleary, the development
of new FPs further into the yellow part
of the visible spectrum would benefit
both multi-color and FRET imaging
studies.
In this issue of Chemistry & Biology,
Hoi et al. (2013) present the development
of a new YFP derived from the Zoanthus
button polyp protein zFP538 (Figures 1A
and 1B) (Zagranichny et al., 2004). Native
zFP538 contains a unique three-ring
chromophore not found in other FPs
(Figure 1C). Specifically, the polypeptide
backbone around the central chromo-
phore breaks at the 65-66 amino acid
position and generates a six-membered
ring (Remington et al., 2005). The addition1204 Chemistry & Biology 20, October 24, 20of a double bond in this system likely
extends the conjugation of the chromo-
phore and lowers the peak emission
wavelength into the yellow part of the
visible spectrum (Figure 1D). The native
protein also known as ZsYellow is, how-
ever, relatively dim and strongly tetra-
meric. These characteristics have limited
its use as a fusion partner for imaging
studies.
Here, through a series of rational and
directed evolution procedures, along
with a set of stringent screening assays,
the authors develop a new zFP538mutant
called mPapaya1. Through the addition of
18 mutations, mPapaya1 has an emission
maximum at 541 nm, is brighter than
EGFP, is stable and monomeric, does13 ª2013 Elsevier Ltd All rights reservednot visibly perturb the behavior of several
fusion partners, and should provide
another excellent choice as an in vivo
probe for microscopy and FRET. To
arrive at the final protein, the authors
performed eight rounds of mutagenesis
targeting unique aspects of the zFP538’s
structure or behavior. The first two
rounds used rational mutations informed
by the crystal structure of zFP538 to
disrupt the tetramerization interface of
the four subunits. Similar mutations
have been used to monomerize other
FPs. After these rounds, however, several
features of the protein, including bright-
ness, were compromised. This required
further mutagenesis and screening to
return desirable characteristics to the
protein. Specifically, through directed
evolution, libraries of error-prone PCR-
generated mutants were made and ex-
pressed in bacteria, and the resultant
colonies were screened for color, bright-
ness, and bleaching. Similar directed
evolution/screening methods have been
used in the past to create the dsRed-
based mFruit fluorescent proteins
(Shaner et al., 2004). The success of
this method illustrates the power of
combining the best aspects of struc-
ture-guided mutations with saturated
directed evolution. Similar success has
been seen in computational protein
design where binding sites or catalytic
sites in a protein are screened in silico
with every possible combination of
amino acids to find supportive interac-
tions or geometries (Fleishman and
Baker, 2012). To develop mPapaya1,
instead of the computer doing the
work, the bacteria, combined with
massive fluorescent screening, accom-
plished the goal. It is clear from the recent
success of both of these approaches
(at the bench or on the computer) that
the ability to evaluate all possible muta-
tions—some not necessarily obvious to
rational design—facilitates successful
protein engineering (Romero and Arnold,
2009).
While many studies have used muta-
genesis to develop new FP colors, the
ability of a protein to perform as a
noninvasive partner is one of the most
important characteristics of a fusion
tag. In this study, after the protein was
fully evolved for brightness, bleaching,
and color, the authors went on to test
the protein’s performance in vivo. First,
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mPapaya1, the protein was evaluated
using the recent protocol of Costantini
et al. (2012). In this assay, a test protein
(mPapaya1, for example) is fused to the
cytoplasmic end of the endoplasmic
reticulum (ER) membrane protein
CytERM. If the fusion pair homo-oligo-
merizes, the structure of the ER is
changed from a tubular network into a
visible network of organized smooth
ER whorls. Thus, counting the percent-
age of cells with whorls indicates the
level of oligomerization of the test pro-
tein. In this study, 83% of cells with
the mPapaya1 fusion had a tubular ER
morphology, compared to 77% of cells
expressing the monomeric control pro-
tein mEGFP, suggesting that mPapaya1
is essentially monomeric. As further
support for its monomeric nature,
mPapaya1 was fused to multiple part-
ners (histone H2B, connexins, tubulin,
and others) and observed with micro-
scopy, and the fusion was seen to not
interfere with the normal trafficking or
localization of these proteins.
As a final test, the authors evaluated
mPapaya1 as a partner for FRET. This
was important, because one of the
motivations to create mPapaya1 was to
find an alternative yellow FRET acceptor.
To test the response of mPapaya1 in a
FRET assay, the authors created a pro-
teolytically-sensitive mPapaya/mTFP1
fusion. This donor/acceptor pair shouldhave a Fo¨rster radius of 5.1 nm. This
fusion showed a strong FRET signal
and a large decrease in FRET upon acti-
vation of the protease both in vitro and
in vivo. Thus, mPapaya1 should act as
an excellent yellow FRET acceptor for
structural studies or the creation of new
biosensors.
Completely rational protein design has
seen limited success. Perhaps this is the
result of the complex and interconnected
nature of a protein’s structure and func-
tion (Fleishman and Baker, 2012). Often,
non-intuitive mutations are needed to
improve the folding, activity, or stability
of a protein. A major boon for FP design
is the ability to rapidly screen for func-
tion—namely, color and intensity. Similar
screening methods to look for other fea-
tures in proteins, such as enzyme activ-
ity, ligand binding, or optical qualities,
are also being combined with massive
directed evolution methods to produce
new engineered proteins with optimized
behaviors (Fleishman and Baker, 2012;
Romero and Arnold, 2009). In addition
to providing an exciting new FP, the
work presented here demonstrates the
ability of directed evolution to fill in
gaps in the collection of nature’s protein
library.REFERENCES
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The goal of structural vaccinology is to enable the design and engineering of improved antigens. In a recent
issue ofChemistry & Biology, Gourlay and colleagues provided evidence that structure-based computational
methods allow prediction of B cell epitopes, a crucial step for antigen selection and optimization in vaccine
development.Understanding the molecular bases of
immune recognition is one of the big
challenges in vaccine development, andthe elucidation of the three-dimensional
(3D) structure of antigens and antigen-
antibody complexes is central to struc-tural vaccinology. This provides knowl-
edge on which structural and dynamic
properties might be responsible for the2013 Elsevier Ltd All rights reserved 1205
